Will IMU’s cancer trials cause a surge in stock price?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Imugene Ltd (ASX:IMU) has one of the most exciting stock stories in the biotech industry. Why? Because IMU strives to cure cancer, through a range of new Immuno oncology therapies. […]